CANN Group (ASX: $CAN) is an industry leader with a focus on the breeding and cultivation of #cannabis, and the manufacture of #medicinalcannabis products.
Melbourne, Victoria
Joined October 2020
- Tweets245
- Following98
- Followers422
- Likes39
Cann Group announced today that it has executed a sale and purchase agreement for $1.7 million and an extension of its NAB working capital facility to 31 March 2025.
canngrouplimited.com/news/fu…
With the increasing presence of medicinal cannabis imports into the local market, Australian cultivators are calling for greater support to promote homegrown products.
canngrouplimited.com/news/ho…
Cann Group recognises Medicinal Cannabis Awareness Week, which begins today.
This AMCA initiative unites experts, patients and the broader community to further educate and gain a greater appreciation of the potential of the medicine to improve health outcomes.
Cann is pleased to invite shareholders, investors and interested parties to a webinar update and Q&A with CEO, Peter Koetsier.
The webinar will be held on Wednesday, 28 February 2024 at 11:00 am (Melbourne time).
Cann Group is proud to be a partner of @AcannabisC
We will be hosting the Network Lounge, so come and say hello.
Join us at Crown Promenade in Melbourne on March 12 and 13 for the must-attend event for the medicinal cannabis industry.
Register today at acannabis.com.au
“I’m lucky that I’m taking on this role as our facility reaches its full potential.”
Introducing Michael Long, our new General Manager - Mildura.
youtu.be/YkS86I4aOeE
Tony Di Pietro has been appointed to the role of Chief Financial Officer and joint Company Secretary.
canngrouplimited.com/news/ne…
It has been a busy year for Cann Group, filled with multiple achievements that are set to catapult the Company into an exciting 2024.
Take a look at our timeline that reflects on the key moments this year.
canngrouplimited.com/news/20…
Cann Group is now just months from achieving 12.5 tonnes of production at the Mildura facility.
The graph below outlines the monthly targets that will see the Company reach the ultimate goal by March next year.
And yes, that is a yield of 732.5kg in November, 110% of our target.
Introducing Billy Freeman, one of the cultivators at our Mildura facility.
Billy arrived at Cann Group a year ago via an initiative Cann has built with are-able, a not-for-profit organisation that aims to help people with a disability find employment.
youtu.be/jrM5Yb0_5Tk
Cann Group is pleased to confirm that it has raised A$2 million via entry into a convertible securities facility.
canngrouplimited.com/news/co…
Cann Group's Head of Research & Development, Filippa Brugliera, outlines some of the key projects that the Company's R&D facility in Bundoora is currently undertaking.
youtu.be/kXO_Rp3s_-U
Cann Group CEO, Peter Koetsier, has been appointed as the Chair of Medicinal Cannabis Industry Australia at its AGM on Wednesday.
canngrouplimited.com/news/ko…
Cann Group CEO, Peter Koetsier, has backed the decriminalisation of home-grown cannabis for personal use, but warned a full legal system risked undermining the health of Australians.
To read the full article, subscribe to Cannabiz.
canngrouplimited.com/news/de…
Cann Group has seen a second consecutive month of record yield at its flagship Mildura facility.
canngrouplimited.com/news/se…
With our Mildura and Bundoora R&D facilities now both fully operational, the Company has a strong platform from which to achieve our goal of being Australia’s premier B2B supplier of medicinal cannabis.
Watch the video presented at Cann's 2023 AGM.
youtu.be/G0f9BCjiud0
Cann Group’s Product Innovation & Development Manager, James Yodgee, discusses the growth of the Company's diverse product portfolio.
canngrouplimited.com/news/ne…
